Gene · 345611
Papers1,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From gut to pancreas: Shared genetic susceptibility and biological convergence in acute pancreatitis and Crohn's disease. | PLoS One | 2026 | 42726709 | PubTator, text mining | PubMed |
| Epigenetic profiling reveals M1 macrophages as the primary drivers of trained immunity in HSV-1 latently infected mice. | PLoS Pathog | 2026 | 42715287 | PubTator, text mining | PubMed |
| IRGM genetic variants associate with tuberculosis disease in a European population. | Int J Infect Dis | 2026 | 42537778 | PubTator, text mining | PubMed |
| m6A RNA methylation modulates IFN-γ-stimulated intestinal epithelial cell-intrinsic antiparasitic defense. | PLoS Pathog | 2026 | 42475356 | PubTator, text mining | PubMed |
| Biomarkers in the pathogenesis and diagnosis of Crohn's perianal fistulas: a systematic review. | Tech Coloproctol | 2026 | 42329424 | PubTator, text mining | PubMed |
| Pro-inflammatory microbiota mediates the effect of host risk genes in Crohn's disease. | Front Microbiol | 2026 | 42317752 | PubTator, text mining | PubMed |
| mSphere of Influence: Host-pathogen interactions-the fascinating world of molecular interplay. | mSphere | 2026 | 42017674 | PubTator, text mining | PubMed |
| Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition. | Explor Target Antitumor Ther | 2026 | 42003977 | PubTator, text mining | PubMed |
| Irgm1 Restrains CD8+ T Cell Cytokine Production and Apoptosis via Cell-Extrinsic Regulation of Type I Interferon Signaling. | Eur J Immunol | 2026 | 41906618 | PubTator, text mining | PubMed |
| IRGM1-IRF7 Axis Controls Macrophage Chemotaxis to Orchestrate Skeletal Muscle Regeneration. | Inflammation | 2026 | 41862677 | PubTator, text mining | PubMed |
| Mechanism of action and clinical application of autophagy in multiple sclerosis (Review). | Int J Mol Med | 2026 | 41860040 | PubTator, text mining | PubMed |
| Targeting cell death in Crohn's disease: from mechanisms to medicines. | Cell Death Discov | 2026 | 41807349 | PubTator, text mining | PubMed |
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| Case Report: Interleukin-23 blockade achieves sustained remission in Niemann-Pick type C-associated Crohn's disease refractory to anti-tumor necrosis factor therapy. | Front Immunol | 2026 | 41798938 | PubTator, text mining | PubMed |
| Neutrophil Irgm1 ameliorates sepsis-induced myocardial dysfunction by promoting Alox15 degradation. | Redox Biol | 2026 | 41795420 | PubTator, text mining | PubMed |
| Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis. | Front Cell Infect Microbiol | 2026 | 41778020 | PubTator, text mining | PubMed |
| Crohn's Disease in Malaysia: Could Application of the Precautionary Principle Reduce Future Incidence? | Microorganisms | 2026 | 41753582 | PubTator, text mining | PubMed |
| Genetic Predisposition to MASLD: Potential for Therapeutic Management. | Int J Mol Sci | 2026 | 41752069 | PubTator, text mining | PubMed |
| Irgm1 Improves Postinfarction Cardiac Repair by Promoting Neutrophil Clearance and Efferocytosis. | Adv Sci (Weinh) | 2026 | 41738282 | PubTator, text mining | PubMed |
| Macrophages From Latently Infected Mice Have Trained Immunity to HSV-1. | Invest Ophthalmol Vis Sci | 2026 | 41733413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/345611/papers